The overall pay package, which included salary, bonus, stock and other incentive pay, represented a 17% increase from Bourla’s compensation in 2019, when he was paid a total of $17.9 million, according to a securities filing on Friday.
Bourla has become the highly visible face of a company at the center of global efforts to halt the Covid-19 pandemic. The vaccine that Pfizer developed with German partner
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.